secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001193125-24-164461
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viridian shareholders approve 2M share increase for equity plan; directors elected
--------------------------------------------------------------------------------

- Amendment to 2016 equity plan approved (32.2M for, 24.3M against), adding 2M shares to reserve.
- Class III directors Stephen Mahoney and Arlene M. Morris elected; Morris received 24.9M withheld votes.
- Advisory vote on exec compensation passed: 32.8M for, 23.7M against.
- Ratification of KPMG as independent auditor passed: 58.4M for, 31.7K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/0001193125-24-164461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312524164461/d857947d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-164461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer